Cargando…

Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells

Endometrial Carcinoma (EMCA) is the most common gynecologic malignancy and the fourth most common malignancy in women in the United States. Yes-associated protein (YAP) is a potent transcription coactivator acting via binding to the TEAD transcription factor, and plays a critical role in organ size...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasari, Venkata Ramesh, Mazack, Virginia, Feng, Wen, Nash, John, Carey, David J., Gogoi, Radhika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438678/ https://www.ncbi.nlm.nih.gov/pubmed/28404908 http://dx.doi.org/10.18632/oncotarget.15614

Ejemplares similares

Differential gene expression induced by Verteporfin in endometrial cancer cells
por: Bang, Lisa Gahyun, et al.
Publicado: (2019)

Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2020)

Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
por: Tsujiura, Masahiro, et al.
Publicado: (2014)

Docking analysis of verteporfin with YAP WW domain
por: Kandoussi, Ilham, et al.
Publicado: (2017)

Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer
por: Shivakumar, Manu, et al.
Publicado: (2019)

Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
por: Wei, Lina, et al.
Publicado: (2023)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression
por: Condurat, Alexandra-Larisa, et al.
Publicado: (2023)

Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner
por: Hasegawa, Takashi, et al.
Publicado: (2021)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)

Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019)

Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
por: Feng, Juntao, et al.
Publicado: (2016)

YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions
por: Huang, Yunying, et al.
Publicado: (2022)

Correction to: Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019)

Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
por: Dong, Liang, et al.
Publicado: (2018)

Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer
por: Deng, Boer, et al.
Publicado: (2023)

Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP‐TEAD complex
por: Wei, Honglong, et al.
Publicado: (2017)

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
por: Morice, Sarah, et al.
Publicado: (2020)

Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1
por: Liu, Kui, et al.
Publicado: (2019)

Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma
por: Liu, Xiangyu, et al.
Publicado: (2019)

A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
por: Spurr, Liam F., et al.
Publicado: (2022)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
por: Morishita, Takanobu, et al.
Publicado: (2016)

OR02-4 YAP1 Overexpression Associates With Worse Prognosis In Patients With Adrenal Tumors And YAP1 Inhibition By Verteporfin Reduces Tumorigenicity And Reverses Epithelial-mesenchymal Transition In Adrenocortical Tumor Cells
por: Bellido More, Candy, et al.
Publicado: (2019)

Verteporfin as a Medical Treatment in Peyronie’s Disease
por: Mohede, Daan C.J., et al.
Publicado: (2018)

The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
por: Wei, Changran, et al.
Publicado: (2020)

Anti-proliferative and cytotoxic activity of rosuvastatin against melanoma cells
por: Maj, Malgorzata, et al.
Publicado: (2016)

Methanolic extract of Euchelus asper exhibits in-ovo anti-angiogenic and in vitro anti-proliferative activities
por: Agrawal, Sweta, et al.
Publicado: (2017)

Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
por: Shamul, James G, et al.
Publicado: (2019)

Verteporfin Is a Promising Anti-Tumor Agent for Cervical Carcinoma by Targeting Endoplasmic Reticulum Stress Pathway
por: Wang, Meng, et al.
Publicado: (2020)

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim, Shaheen P, et al.
Publicado: (2013)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
por: Sirks, Marc J., et al.
Publicado: (2022)

EGF Receptor Signaling Modulates YAP Activation and Promotes Experimental Proliferative Vitreoretinopathy
por: Zhang, Wei, et al.
Publicado: (2022)

In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs
por: Billack, Blase, et al.
Publicado: (2008)

Prolactin Enhances the Proliferation of Proliferative Endometrial Glandular Cells and Endometrial Cancer Cells
por: Yamaguchi, Munekage, et al.
Publicado: (2019)

Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity
por: Ritchie, Shawn A, et al.
Publicado: (2011)

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma
por: Lui, Jason W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5jqj4u92dhuqddj097f6rjvd69